In a rare move, the FDA recommended a minimum of 5% weight-loss for drug developers seeking to establish the efficacy of ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected ...

Three GLP-1 drugs are best at helping obese and overweight people drop weight, including one that hasn’t yet been ap ...

Health experts have cited concerns about the medications' long-term impacts on eating behaviors and body image, especially given the developing nature of a teenager’s body and brain. “The advice from ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

New FDA draft guidance for drugmakers focuses on trial design for developing obesity treatments. Read more here.

New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar.

Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...

The startup, which has already raised more than half a billion dollars, released Phase 2 results that could position its drug ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, manufactured by Novo Nordisk. Reuters Eli Lilly said Wednesday that its obesity drug Zepbound ...

As the weight-loss drugs become more popular, consumer habits are starting to reflect changing consumption behavior, ...